Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Sunitinib in Metastatic Clear Cell Renal Cell Carcinoma
NCT01069770Phase 2Unknown
- Sponsor
- Korean Urological Oncology Society
- Start
- Jul 2009
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in clear cell renal cell carcinoma (ccRCC), sponsored by Korean Urological Oncology Society. Status: unknown.
02
Drugs
sunitinib
03
Conditions
clear cell renal cell carcinoma (ccRCC)
Beyond the preview
Go deeper on NCT01069770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01069770.